88IV - Public company info - Wuhan YZY Biopharma Co. Ltd.

Input the stock code or the company name

Wuhan YZY Biopharma Co. Ltd. - H Shares, 02496.HK - Cash Flow	2022-12	2021-12
Net Cash Flow from Operating Activities	-176,703	-98,710
Net Cash Flow from Return on Investments & Servicing of Finance	-2,185	-3,836
Interest Received	283	162
Interest Paid	-2,468	-3,998
Dividend Received	0	0
Dividend Paid	0	0
Others	0	0
Taxes (Paid) / Refunded	0	0
Net Cash Flow from Investing Activities	5,521	-20,095
Additions to Fixed Assets	-1,411	-1,903
Disposal of Fixed Assets	0	47
Increase in Investments	-378,500	-481,600
Decrease in Investments	351,000	462,100
Net Cash Flow with Related Parties	0	-71,070
Others	34,432	72,331
Net Cash Flow before Financing Activities	-173,367	-122,641
Net Cash Flow from Financing Activities	243,802	85,032
New Loans	76,500	28,000
Loans Repayment	-28,436	-21,411
Fixed Income/Debt Instruments	0	0
Repayment of Fixed Income/Debt Instruments	0	0
Equity Financing	200,000	149,910
Net Cash Flow with Related Parties	0	-71,070
Others	-4,262	-397
Increase(Decrease) in Cash & Cash Equivalents	70,435	-37,609
Cash & Cash Equivalents at Beginning of Year	83,085	120,694
Net Cash Flow due to Change in Exchange Rate/Others	0	0
Cash & Cash Equivalents at End of Year	153,520	83,085
Currency	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Wuhan YZY Biopharma Co. Ltd. - H Shares , 02496.HK